cached image

Gemma Casadesus, PhD, Tufts University

Neuroscience Case Western Reserve University, Cleveland Heights, OH, United States 
"Gemma Casadesus"

Mean distance: 16.91 (cluster 28)
Cross-listing: Neuropathology Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Correia SC, Alves MG, Oliveira PF, et al. (2022) Hypoxic preconditioning averts sporadic Alzheimer's disease-like phenotype in rats: a focus on mitochondria. Antioxidants & Redox Signaling
Corrigan RR, Piontkivska H, Casadesus G. (2021) Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment. Current Neuropharmacology
Mey M, Bhatta S, Casadesus G. (2021) Luteinizing hormone and the aging brain. Vitamins and Hormones. 115: 89-104
Cunnane SC, Trushina E, Morland C, et al. (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nature Reviews. Drug Discovery
Ettcheto M, Sánchez-López E, Gómez-Mínguez Y, et al. (2020) Correction to: Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease. Molecular Neurobiology
Servizi S, Corrigan RR, Casadesus G. (2020) The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer’s Disease Current Pharmaceutical Design
Busquets O, Ettcheto M, Eritja À, et al. (2019) c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments. Journal of Molecular Medicine (Berlin, Germany)
Folch J, Olloquequi J, Ettcheto M, et al. (2019) The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia. Frontiers in Aging Neuroscience. 11: 236
Grizzanti J, Corrigan R, Servizi S, et al. (2019) Amylin Signaling in Diabetes and Alzheimer's Disease: Therapy or Pathology? Journal of Neurology & Neuromedicine. 4: 12-16
Patrick S, Corrigan R, Grizzani J, et al. (2019) Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms. Journal of Alzheimer's Disease : Jad
See more...